spironolactone and Hypothyroidism
spironolactone has been researched along with Hypothyroidism in 3 studies
Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.
Hypothyroidism: A syndrome that results from abnormally low secretion of THYROID HORMONES from the THYROID GLAND, leading to a decrease in BASAL METABOLIC RATE. In its most severe form, there is accumulation of MUCOPOLYSACCHARIDES in the SKIN and EDEMA, known as MYXEDEMA. It may be primary or secondary due to other pituitary disease, or hypothalamic dysfunction.
Research Excerpts
Excerpt | Relevance | Reference |
---|---|---|
" The recent introduction of a novel, long-acting testosterone formulation (testosterone undecanoate) which only requires one intramuscular injection every 3 months, together with the already available hydroalcoholic testosterone gels, appear to be promising alternatives to the previous standard substitution therapy for male hypogonadism." | 4.83 | [The latest developments in endocrinology 2004/2005]. ( Fottner, C; Weber, MM, 2006) |
Research
Studies (3)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Drzayich Antol, D | 1 |
Waldman Casebeer, A | 1 |
Khoury, R | 1 |
Michael, T | 1 |
Renda, A | 1 |
Hopson, S | 1 |
Parikh, A | 1 |
Stein, A | 1 |
Costantino, M | 1 |
Stemkowski, S | 1 |
Bunce, M | 1 |
Nevo, N | 1 |
Abu-Abeid, S | 1 |
Hazzan, D | 1 |
Lahat, G | 1 |
Nachmani, I | 1 |
Eldar, SM | 1 |
Zhang, L | 1 |
Xia, X | 1 |
Zhong, Y | 1 |
Xie, D | 1 |
Liu, S | 1 |
Wang, X | 1 |
Tu, J | 1 |
Faconti, L | 1 |
Mills, CE | 1 |
Govoni, V | 1 |
Gu, H | 1 |
Morant, S | 1 |
Jiang, B | 1 |
Cruickshank, JK | 1 |
Webb, AJ | 1 |
Lin, J | 1 |
Wu, YJ | 1 |
Liang, X | 1 |
Ji, M | 1 |
Ying, HM | 1 |
Wang, XY | 1 |
Sun, X | 1 |
Shao, CH | 1 |
Zhan, LX | 1 |
Zhang, Y | 1 |
Czamara, K | 1 |
Karnas, E | 1 |
Majka, Z | 1 |
Wojcik, T | 1 |
Zuba-Surma, EK | 1 |
Baranska, M | 1 |
Kaczor, A | 1 |
Liu, X | 1 |
Zhou, F | 1 |
Yang, Y | 1 |
Wang, W | 1 |
Niu, L | 1 |
Zuo, D | 1 |
Li, X | 1 |
Hua, H | 1 |
Zhang, B | 1 |
Kou, Y | 1 |
Guo, J | 1 |
Kong, F | 1 |
Pan, W | 1 |
Gao, D | 1 |
Meves, JM | 1 |
Sun, H | 1 |
Xue, M | 1 |
Zhang, Q | 1 |
Wang, Y | 1 |
Tang, R | 1 |
Iso, T | 1 |
Haruyama, H | 1 |
Sunaga, H | 1 |
Matsui, H | 1 |
Matsui, M | 1 |
Tanaka, R | 1 |
Umbarawan, Y | 1 |
Syamsunarno, MRAA | 1 |
Putri, M | 1 |
Yamaguchi, A | 1 |
Hanaoka, H | 1 |
Negishi, K | 1 |
Yokoyama, T | 1 |
Kurabayashi, M | 1 |
Palomo-Briones, R | 1 |
Esquivel-González, S | 1 |
Aizpuru, A | 1 |
Gómez-Hernández, N | 1 |
Casas-Flores, S | 1 |
Barba de la Rosa, AP | 1 |
Arriaga, S | 1 |
Peterson, ME | 1 |
Carothers, MA | 1 |
Gamble, DA | 1 |
Rishniw, M | 1 |
Olsen, EA | 1 |
Messenger, AG | 1 |
Shapiro, J | 1 |
Bergfeld, WF | 1 |
Hordinsky, MK | 1 |
Roberts, JL | 1 |
Stough, D | 1 |
Washenik, K | 1 |
Whiting, DA | 1 |
Fottner, C | 1 |
Weber, MM | 1 |
Reviews
1 review available for spironolactone and Hypothyroidism
Article | Year |
---|---|
[The latest developments in endocrinology 2004/2005].
Topics: Adrenal Gland Neoplasms; Adult; Bone Density Conservation Agents; Chronic Kidney Disease-Mineral and | 2006 |
Trials
1 trial available for spironolactone and Hypothyroidism
Article | Year |
---|---|
Topics: Adult; Aged; Animals; Astrocytes; Bariatric Surgery; Beta vulgaris; Bioreactors; Biotechnology; Bloo | 2018 |
Other Studies
1 other study available for spironolactone and Hypothyroidism
Article | Year |
---|---|
Evaluation and treatment of male and female pattern hair loss.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Administration, Topical; Adoles | 2005 |